These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38240814)

  • 1. [Diagnostics and treatment of large vessel vasculitis].
    Bauer CJ; Schäfer VS
    Inn Med (Heidelb); 2024 Feb; 65(2):107-113. PubMed ID: 38240814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
    Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1071-1087. PubMed ID: 34235871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Therapeutic Approaches to Large-Vessel Vasculitis.
    Kaymakci MS; Warrington KJ; Kermani TA
    Annu Rev Med; 2024 Jan; 75():427-442. PubMed ID: 37683286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
    Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC
    J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of large-vessel vasculitis.
    Salvarani C; Hatemi G
    Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotherapies in large vessel vasculitis.
    Pazzola G; Muratore F; Pipitone N; Salvarani C
    Rev Med Interne; 2016 Apr; 37(4):274-8. PubMed ID: 26383765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
    Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
    Arthritis Rheumatol; 2021 Aug; 73(8):1349-1365. PubMed ID: 34235884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
    Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
    Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey.
    Abe Y; Fujii T; Miyawaki Y; Sugihara T; Uchida HA; Maejima Y; Watanabe Y; Hashimoto T; Miyamae T; Nakaoka Y; Harigai M; Tamura N
    Mod Rheumatol; 2024 Oct; 34(6):1194-1201. PubMed ID: 38590042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects].
    Chaigne-Delalande S; de Menthon M; Lazaro E; Mahr A
    Presse Med; 2012 Oct; 41(10):955-65. PubMed ID: 22940467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.
    Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
    Arthritis Res Ther; 2019 Dec; 21(1):304. PubMed ID: 31888748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM
    Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Large Vessel Vasculitides: Giant Cell Arteritis and Takayasu Arteritis - Similarities and Differences].
    Gloor AD; Christ L
    Ther Umsch; 2022 Jun; 79(5):221-228. PubMed ID: 35583023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term complications, monitoring and interventional treatment of large vessel vasculitis].
    Wipfler-Freißmuth E; Dejaco C; Both M
    Z Rheumatol; 2020 Aug; 79(6):523-531. PubMed ID: 32430565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
    Narváez J; Estrada P; LLop D; Vidal-Montal P; Brugarolas E; Maymó-Paituvi P; Palacios-Olid J; Nolla JM
    Semin Arthritis Rheum; 2023 Apr; 59():152166. PubMed ID: 36645992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
    Maksimowicz-McKinnon K; Clark TM; Hoffman GS
    Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.